For regulatory professionals, the idea of cutting hundreds of hours of painstaking work down to just a few clicks has always felt out of reach.
We know that migrating from complex, entrenched legacy systems can be daunting – especially when you’re managing large volumes of data and critical processes. That’s
Loba biotech GmbH, a wholly owned GMP manufacturing subsidiary of pharmaand GmbH (pharma&), has chosen Generis’ CARA Life Sciences Platform to launch its digital Quality
AI-powered CARA Platform and new Starter Pack Model fuel rapid expansion across regulated sectors LONDON, UK – Generis, creator of the CARA Platform and CARA
Cytonics, a biotechnology research and development company specializing in diagnostics and therapeutics for osteoarthritis, has selected Generis, the provider of the AI-enabled CARA Life Sciences
Kwizda Pharma, a division of Kwizda Holding GmbH and a leader in the Austrian healthcare market, has selected the CARA Life Sciences Platform from Generis,
© Copyright 2002-2026, Generis Enterprise Technology Limited, all rights reserved
